Looking More Like Fish Is, Indeed, Brain Food

September 2003
Tufts University Health & Nutrition Letter;Sep2003, Vol. 21 Issue 7, p1
Discusses the benefits from eating fish in reducing the risk for Alzheimer disease. Risk factors of Alzheimer's disease; Importance of docosahexaenoic acid (DHA) in phospholipids; Information on the recipe of Greens with Salmon, Dill, & Lemon Dressing.


Related Articles

  • Fatty Aspirin: A New Perspective in the Prevention of Dementia of Alzheimer's Type? Pomponi, Massimiliano; Gioia, Annamaria D.; Bria, Pietro; Lucio Pomponi, Massimo Fabio // Current Alzheimer Research;Dec2008, Vol. 5 Issue 5, p422 

    Alzheimer's disease (AD) leads to a dramatic decline in cognitive abilities and memory. A more modest disruption of memory often occurs in normal aging and the same circuits that are devastated through degeneration in AD are vulnerable to sub-lethal age-related changes that alter synaptic...

  • The Disease i Preventive Power of Fish and Olives.  // Life Extension;Winter 2005/2006 Special Edition, p32 

    The article discusses the role of the Mediterranean diet in preventing diseases. Fish and olives are the main components of the Mediterranean diet. Recent studies associate this diet with sharply lower cardiovascular risk, reduced cancer risk, and increased life span. Critical components of this...

  • To Eat or Not to Eat - Fish. Lee, Katherine // Working Mother;Aug/Sep2007, Vol. 30 Issue 6, p96 

    The article discusses a British and American study suggesting that children whose mothers ate more fish during pregnancy showed better neurological function than children whose mothers ate small amounts of fish. Fish are high in protein and long-chain fatty acids such omega-3, including DHA,...

  • THE DHA DEBATE. Vosburgh, Robert // SN: Supermarket News;Spring2008 Whole Health Supplement, Vol. 56, p20 

    The article focuses on the health benefit of Docosahexaenoic acid (DHA), a long-chain polyunsaturated fatty acid, for adults. Major studies are under way to determine if DHA has any influence over age-related conditions like Alzheimer's disease; others recently evaluated its ability to prevent...

  • Long-Chain Omega-3 Fatty Acids and Optimization of Cognitive Performance. Muldoon, Matthew F.; Ryan, Christopher M.; Yao, Jeffrey K.; Conklin, Sarah M.; Manuck, Stephen B. // Military Medicine;Nov2014 Supplement, p95 

    Low consumption of the omega-3 fatty acids, eicosapentaenoic and docosahexaenonic acids, is linked to delayed brain development and, in late life, increased risk for Alzheimer’s disease. The current review focuses on cognitive functioning during midlife and summarizes available scientific...

  • Scientists Unravel Neuroprotective Effects of Fish Oil. Wagner, Elizabeth // Life Extension;Dec2005, Vol. 11 Issue 12, p14 

    Reports on Louisiana State University scientists' claim that the omega-3 fatty acid docosahexaenoic acid (DHA) reduces levels of a protein known to cause damaging plaques in the brains of Alzheimer's patients, and a derivative of DHA helps protect brain cells against cell death. Sources of DHA;...

  • Boosting intake of omega-3 'could ward off' Alzheimer's. Tanday, Sanjay // GP: General Practitioner;3/27/2009, p9 

    The article cites a study which reveals that increasing dietary intake of omega-3 reduces the risk of developing Alzheimer's disease. The study, which involved mice that have been fed a diet enriched with docosahexaenoic acid (DHA), has shown that mice on a DHA diet did better in cognition...

  • Omega-3 Slashes Dementia Risk.  // Natural Life;Jan/Feb2007, Issue 113, p40 

    The article discusses how omega-3 fatty acid docosahexaenioc acid (DHA) is responsible for decreasing the risk of dementia and Alzheimer's disease. A study found that people who have higher levels of DHA in their blood have a 47% lower risk of developing dementia and Alzheimer's disease. Levels...

  • What was lost in translation in the DHA trial is whom you should intend to treat. Frautschy, Sally A.; Cole, . Cole // Alzheimer's Research & Therapy;2011, Vol. 3 Issue 1, p1 

    The results of a randomized double-blind placebo-controlled trial with docosahexaenoic acid (DHA) supplementation in mild to moderate Alzheimer's disease (AD) published by Quinn and colleagues in JAMA argues against overall efficacy of DHA in slowing progression. However, certain caveats in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics